- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05645159
Blended Learning in Future Physiotherapy Professionals
April 18, 2023 updated by: David Hernández-Guillén, University of Valencia
Effectiveness of a Heart Disease Blended Learning Program in Future Physiotherapy Professionals: A Prospective Study
Blended Learning (BL) is proving to be an effective method of teaching within the health professions .
However, there are still scarce studies on BL conducted with undergraduate physiotherapy students.
Therefore, the aim of this study was to determine the effectiveness of a heart disease BL programme in knowledge, motivation, engagement, design of the programme instructions and learning behaviours in physiotherapy students.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
124
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Valencia, Spain, 46010
- University of Valencia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- studying a Physiotherapy Degree at the aforementioned University
- to be willing to participate
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Physiotherapy students
The participants performed an 8-week heart disease blended learning program.
|
The intervention included face-to-face classes and online resources (Moodle, online syllabus, videos, websites, podcasts, activities, apps, forums, emails, tutoring).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 0 weeks
|
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no).
Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
|
0 weeks
|
|
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 4 weeks
|
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no).
Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
|
4 weeks
|
|
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 8 weeks
|
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no).
Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
|
8 weeks
|
|
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 12 weeks
|
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no).
Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
|
12 weeks
|
|
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 20 weeks
|
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no).
Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
|
20 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of the Dader Method in Cardiovascular Risk of Patients with Risk Factors or Cardiovascular Disease Questionnaire (EMDADER)
Time Frame: 0, 4, 8, 12 and 20 weeks
|
EMDADER is composed of 10 multiple-choice questions with four answer options on coronary artery disease and risk factors, and two questions to report weight and height.
Total score ranges from 0 to 10 (0=poorest knowledge, 10=best knowledge).
|
0, 4, 8, 12 and 20 weeks
|
|
Academic Motivation Scale and Attributional Styles Questionnaire
Time Frame: 4, 8 weeks
|
The tool is composed of 24 items, using a 7-point Likert scale: from 1 (totally disagree) to 7 (totally agree).
The scale integrates three domains related to learning motivation: Intrinsic Motivation (9 items), Performance Motivation (7 items) and Extrinsic Motivation (7 items).
The maximum score is 7.
The scale is prepared to add the different items even if they measure different items.
They will not be interpreted separately.
|
4, 8 weeks
|
|
Student Engagement Questionnaire
Time Frame: 4, 8 weeks
|
It is a 35-item questionnaire, scored on a five-point Likert scale (1=totally disagree, 5=totally agree).
The questionnaire is divided into five dimensions: Intellectual Capabilities (items 1-10), Working Together (items 11-16), Teaching (items 17-25), Teacher-student Relationship (items 26-29), and Student-student Relationship (items 30-35).
The maximum score of the questionnaire is 5.
The scale is prepared to add the different items even if they measure different items.
They will not be interpreted separately.
|
4, 8 weeks
|
|
Community of Inquiry Survey
Time Frame: 0, 4, 8, 12 and 20 weeks
|
A 34-item questionnaire, scored on a five-point Likert scale (1=strongly disagree, 5=strongly agree) that includes three dimensions: i) Cognitive Presence (items 1-13), related to the degree to which participants are able to construct meaning and knowledge through continuous communication, reflection, and discussion; ii) Social Presence (items 14-22), related to the ability of participants to identify with the community, communicating and developing interpersonal relationships; iii) Teaching Presence (items 23-34), referring to the design, guidance and direction, on the part of teachers, of cognitive and social processes with the purpose of achieving the result of meaningful learning in students.
The maximum score of the questionnaire is 5.
The scale is prepared to add the different items even if they measure different items.
They will not be interpreted separately.
|
0, 4, 8, 12 and 20 weeks
|
|
Learning behaviours (I)
Time Frame: 0, 4, 8, 12 and 20 weeks
|
Number of downloads were retrieved and collected from the institution's Moodle platform Virtual ClassroomTM, through class progress
|
0, 4, 8, 12 and 20 weeks
|
|
Learning behaviours (II)
Time Frame: 0, 4, 8, 12 and 20 weeks
|
Number of topics visited were retrieved and collected from the institution's Moodle platform Virtual ClassroomTM, through class progress
|
0, 4, 8, 12 and 20 weeks
|
|
Learning behaviours (III)
Time Frame: 0, 4, 8, 12 and 20 weeks
|
The score of questionnaires were retrieved and collected from the institution's Moodle platform Virtual ClassroomTM, through class progress
|
0, 4, 8, 12 and 20 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: David Hernández-Guillén, PT, PhD, University of Valencia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
February 28, 2021
Study Completion (Actual)
June 30, 2021
Study Registration Dates
First Submitted
November 25, 2022
First Submitted That Met QC Criteria
December 7, 2022
First Posted (Actual)
December 9, 2022
Study Record Updates
Last Update Posted (Actual)
April 19, 2023
Last Update Submitted That Met QC Criteria
April 18, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BL_HEART_01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
Nantes University HospitalDirectorate of Health Care SupplyRecruitingHeart Diseases | Heart Failure | Heart Valve DiseasesFrance
-
Abiomed Inc.CompletedHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
National Defense Medical Center, TaiwanRecruiting
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
Shanghai Zhongshan HospitalCompletedElectrocardiogram, Valvular Heart DiseaseChina, United Kingdom
-
University of Maryland, BaltimoreCSL BehringTerminatedHeart Failure,Congestive | Heart Disease End StageUnited States
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
Clinical Trials on Blended learning in heart disease
-
University of ValenciaMarta Aguilar RodriguezCompletedAttitude | Knowledge | Ethics
-
National Taipei University of Nursing and Health...Completed
-
Centre for Evidence-Based Practice, BelgiumBelgian Red Cross; Rwanda Red CrossCompletedEmergencies | Injuries | Illness PhysicalRwanda
-
University of BernCompletedUltrasonography | Educational TechniquesSwitzerland
-
University of ValenciaCompletedLearning | StudentsSpain
-
Ruhr University of BochumUniversity of Cologne; University of Koblenz-Landau; Philipps Universität MarburgCompletedDiagnosis, PsychiatricGermany
-
University of Southern DenmarkDanish Heart Foundation; Odense Municipality, DenmarkEnrolling by invitationRehabilitation | Heart Disease | Mental Health OutcomesDenmark
-
Xu TaoCompletedNursing Education | Smart ClassroomChina
-
Chinese University of Hong KongCompletedCommunication | Self Efficacy | NursingHong Kong
-
Chang Gung University of Science and TechnologyCompleted